Immune Sensitization to Mycobacterium tuberculosis Among Young Children with and without Tuberculosis
Pathogens · 2025
DOI: 10.3390/pathogens14090924 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von Jesús Gutierrez und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population and Quantitative Science, Case Western Reserve School of Medicine, Cleveland, OH 44106, USA. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Identification of young children with Mycobacterium tuberculosis (Mtb) infection is critical to curb pediatric morbidity and mortality. The optimal test to identify young children with Mtb infection remains controversial. Using a tuberculosis (TB) household contact (HHC) study design among 130 Ugandan children less than 5 years of age with Mtb exposure, this study was conducted to determine the following: (1) the prevalence of Mtb immune sensitization in young children heavily exposed to TB using both the tuberculin skin test (TST) and QuantiFERON Gold Plus (QFT-Plus) interferon gamma release assay, and to examine the concordance of these two tests; and (2) the diagnostic accuracy of TST and QFT-plus for confirmed and unconfirmed TB in young children. Prevalence of Mtb immune sensitization was determined using TST at both 5 mm and 10 mm thresholds for positivity; manufacturer’s thresholds were utilized to establish QFT-Plus positivity. Concordance analysis between TST and QFT-Plus results was performed, including correlation between QFT-Plus tube TB.1 and tube TB.2. The sensitivity and specificity of TST and QFT-Plus for confirmed and unconfirmed TB was determined, and a logistic regression model was utilized to estimate the odds of TB. A 5 mm TST threshold identified the most children with Mtb sensitization (49.2%) and had moderate agreement with QFT-Plus (Cohen’s Kappa 0.59). The odds of TB were two times higher among children with a positive TST using a 5 mm threshold. Concordance between 10 mm TST threshold and QFT-Plus was substantial (Cohen’s Kappa 0.65), with higher concordance observed among older children (2–5 years). The QFT-Plus tube TB.1 and tube TB.2 results were highly correlated. Positive TST using a 5 mm threshold demonstrated the highest sensitivity for TB (60%), whereas QFT-Plus testing demonstrated the highest specificity (72%). Overall, our findings support that among a population of young, BCG-vaccinated children with heavy household exposure to TB, the TST using a 5 mm threshold identified more children with evidence of Mtb immune sensitization, and children with TB disease, than the QFT-Plus. These findings are highly relevant for children who are TB HHCs in endemic settings, and most at risk for TB following an exposure. We recommend that TST testing continue to be performed to assess for Mtb sensitization in young, TB-exposed children in TB-endemic settings to both prioritize provision of preventive therapy and to aide in diagnosis of pediatric TB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Population and Quantitative Science, Case Western Reserve School of Medicine, Cleveland, OH 44106, USA.
- Uganda-Case Western Reserve University Research Collaboration, Kampala 25601, Uganda.
- School of Medicine, Oregon Health and Science University, Portland, OR 97239, USA.
- Department of Radiology and Radiotherapy, College of Health Sciences, Makerere University, Kampala 7072, Uganda.
- Joint Clinical Research Centre, Kampala 10005, Uganda.
- Department of Paediatrics, School of Medicine College of Health Sciences, Makerere University, Kampala 7072, Uganda.
ORCID-Profile: Jesús Gutierrez, Mitchka Mohammadi, John Mukisa, Catherine M Stein
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- the National Institute of Allergy and Infectious Diseases at the National Institutes of Health
Zitieren
APA
Gutierrez, J., Malone, L. L., Mohammadi, M., Mukisa, J., Atuhairwe, M., Mwesigwa, S. P. G., Athieno, S., Buwule, S., Ameda, F., Nalukwago, S., Mupere, E., Stein, C. M., & Lancioni, C. L. (2025). Immune Sensitization to Mycobacterium tuberculosis Among Young Children with and without Tuberculosis. Pathogens. https://doi.org/10.3390/pathogens14090924
Vancouver
Gutierrez J, Malone LL, Mohammadi M, Mukisa J, Atuhairwe M, Mwesigwa SPG, et al. Immune Sensitization to Mycobacterium tuberculosis Among Young Children with and without Tuberculosis. Pathogens. 2025. doi:10.3390/pathogens14090924
BibTeX
@article{Gutierrez2025,
author = {Gutierrez, Jesús and Malone, LaShaunda L and Mohammadi, Mitchka and Mukisa, John and Atuhairwe, Michael and Mwesigwa, Simon Peter G and Athieno, Salome and Buwule, Sharon and Ameda, Faith and Nalukwago, Sophie and Mupere, Ezekiel and Stein, Catherine M and Lancioni, Christina L},
title = {Immune Sensitization to Mycobacterium tuberculosis Among Young Children with and without Tuberculosis},
journal = {Pathogens},
year = {2025},
doi = {10.3390/pathogens14090924}
}
EUVIMED